Latest Plasmodium falciparum Stories
A international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead to a new generation of antimalarial drugs capable of not only alleviating symptoms but also preventing the deadly disease.
A study conducted by researchers at the Johns Hopkins Malaria Research Institute and their Zambian colleagues detected contrasting patterns of drug resistance in malaria-causing parasites taken from both humans and mosquitoes in rural Zambia.
For some time now, artemisinin, derived from a Chinese herb, has been the most powerful treatment available against malaria.
A large study from Africa, published in this week's PLoS Medicine, has found that in a direct comparison, three types of new, fast-acting antimalarial artemisinin-based combination therapy drugs (ACTs), which comprise artemisinin derivatives in combination with a partner antimalarial drug, AL (artesunate–mefloquine), ASAQ (artesunate–amodiaquine) and DHAPQ (dihydroartemisinin–piperaquine) are all effective for treating children with uncomplicated malaria.
Malaria is not only native to the New World, but it has been present long before humans existed and has evolved through birds and monkeys.
A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease.
A new malaria vaccine could be the first to tackle different forms of the disease and help those most vulnerable to infection.
Indoor spraying with the insecticide bendiocarb has dramatically decreased malaria transmission in many parts of Benin, new evidence that insecticides remain a potent weapon for fighting malaria in Africa despite the rapid rise of resistance to an entire class of mosquito-killing compounds.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.